Bharat Biotech’s Covaxin gets emergency approval for children aged 2-18 years
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in…
Union Minister of Health and Family Welfare, GoI, launches first commercial batch of COVAXIN manufactured in Ankleshwar, Gujarat
Bharat Biotech, today announced the commercial launch of the first batch of COVAXIN from its Chiron Behring Vaccines…
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre’s Covaxin price
Hyderabad-based vaccine maker Bharat Biotech on Tuesday said the current supply price of its Covid-19 vaccine Covaxin to…
Clinical trial of Bharat Biotech’s Covaxin on children begins at AIIMS Patna
The clinical trial of Bharat Biotech’s COVAXIN on children began at AIIMS Patna. All 15 kids who voluntarily…
Manish Sisodia: Bharat Biotech says can’t give additional Covaxin doses to Delhi
Bharat Biotech has informed the Delhi government that it cannot provide “additional” Covaxin doses to the national capital,…
Serum Institute of India reduces price of Covishield from Rs 400 to Rs 300 for states
Serum Institute of India has decided to reduce the price of its coronavirus vaccine Covishield to Rs 300…
Bharat Biotech expands its manufacturing capacity to produce 70 crore doses of Covaxin annually
Bharat Biotech has expanded its manufacturing capacity across multiple facilities in Hyderabad and Bangalore to produce 700 million…
Covaxin, India’s first indigenous corona vaccine, shows potency of 81 percent
Indigenous Covid-19 vaccine Covaxin has demonstrated interim clinical efficacy of 81 per cent in its phase three trial.…
Covid Vaccine: government likely to buy another 4.5 crore doses of Covidshield Vaccine by April
The government on Wednesday said that it is committed to buying from the Serum Institute further 4.5 crore…